Dr Caroline Kardeby is a Lecturer in Biosciences at Aston University, affiliated with the School of Biosciences and the Aston Research Centre for Health in Ageing within the College of Health and Life Sciences. She holds a PhD in Medical Science (Biomedicine) and is a Marie Curie Alumni Fellow and Advance HE Fellow. Her research focuses on thrombosis in inflammation, particularly the role of platelet and endothelial cell activation in vascular remodeling and neurodegeneration. She has pioneered studies using novel pharmacological tools to elucidate cardiovascular disease mechanisms. Dr Kardeby's education includes a PG Cert in Learning & Teaching (Aston University, 2025), a PhD from Uppsala University (2019), and multiple advanced degrees in biomedical sciences from Uppsala and Örebro Universities. Her clinical background includes registration as a biomedical scientist in Sweden, with experience in clinical chemistry, histology, and fertility laboratories. Her current research projects include investigating thrombotic risks in Parkinson’s disease (funded by the British Heart Foundation) and studying cardiovascular disease risk in South Asians (funded by the Listers Group and Aston University). She also leads a Dunhill Medical Trust-funded study on haemostatic dysregulation as a dementia biomarker. Dr Kardeby’s scientific awards include a Marie Skłodowska-Curie Actions Fellowship (2020-2022) and an Advance HE Fellowship (2025). Her lab includes postdoctoral researcher Dr Marcela Usmari Moraes and students Nusratul Firdaus and Cerys Charles. She actively collaborates with NHS Trusts and international institutions on thrombosis and vascular research.












